Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1640-1644
Published online before print July 17, 2003, doi: 10.1161/01.ATV.0000087036.75849.0B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/9/1640    most recent
01.ATV.0000087036.75849.0Bv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomaszewski, M.
Right arrow Articles by Dominiczak, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomaszewski, M.
Right arrow Articles by Dominiczak, A. F.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1640.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Strikingly Low Circulating CRP Concentrations in Ultramarathon Runners Independent of Markers of Adiposity

How Low Can You Go?

Maciej Tomaszewski; Fadi J. Charchar; Malgorzata Przybycin; Lynne Crawford; A. Michael Wallace; Katarzyna Gosek; Gordon D. Lowe; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Naveed Sattar; Anna F. Dominiczak

From the British Heart Foundation Glasgow Cardiovascular Research Centre (M.T., F.J.C., A.F.D.), Division of Cardiovascular and Medical Sciences, University of Glasgow, UK; Department of Internal Medicine (M.T., M.P., K.G., E.Z.-S., W.G.), Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland; and Department of Pathological Biochemistry (L.C., A.M.W., G.D.L., N.S.), University of Glasgow, UK.

Correspondence to Dr Maciej Tomaszewski, BHF Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, G11 6NT, Glasgow, UK. E-mail mt65{at}clinmed.gla.ac.uk

Objective— This study was undertaken to evaluate to what extent C-reactive protein (CRP) can be reduced by exercise by examining its circulating concentrations in male ultramarathon runners and to determine if low leptin as a robust circulating marker of fat mass could account for low CRP in such men.

Methods and Results— Sixty-seven male ultramarathon runners and 63 sedentary male controls of similar age and body mass index were recruited. CRP and leptin were measured by ELISA and radioimmunoassay, respectively. Median CRP concentration in lean (body mass index <25 kg/m2) marathon runners was less than half control median (0.4 [0.2 to 0.9] mg/L versus 0.9 [0.5 to 2.7] mg/L, P=0.0013) and, more strikingly, in nonlean runners was approximately 26% of control median (0.4 [0.3 to 0.8] mg/L versus 1.5 [0.9 to 2.5] mg/L, P=0.0002). Circulating leptin levels were also substantially lower in lean (45% less) and nonlean (63% less, both P<0.0001) ultramarathon runners. However, interleukin-6 levels were not different. Furthermore, leptin adjustment only minimally attenuated the case-control difference in CRP, suggesting that mechanisms other than fat mass reduction contribute to low concentrations of CRP in marathon runners.

Conclusions— This study suggests that circulating CRP concentrations can be markedly suppressed, independently of total adiposity or indeed fat mass, by intense regular physical exercise.


Key Words: exercise • inflammation • leptin • C-reactive protein • cardiovascular risk




This article has been cited by other articles:


Home page
IOVSHome page
P. T. Williams
Prospective Study of Incident Age-Related Macular Degeneration in Relation to Vigorous Physical Activity during a 7-Year Follow-up
Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. K. Pedersen and M. A. Febbraio
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Physiol Rev, October 1, 2008; 88(4): 1379 - 1406.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
M. G. Flynn, B. K. McFarlin, and M. M. Markofski
State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training
American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235.
[Abstract] [PDF]


Home page
JAMAHome page
S. Mora, I-M. Lee, J. E. Buring, and P. M Ridker
Association of Physical Activity and Body Mass Index With Novel and Traditional Cardiovascular Biomarkers in Women
JAMA, March 22, 2006; 295(12): 1412 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tomaszewski, F. J. Charchar, E. Zukowska-Szczechowska, W. Grzeszczak, and A. F. Dominiczak
Letter re: Inflammation and Lipoprotein Changes with Protracted Exercise
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4981 - 4981.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Kasapis and P. D. Thompson
The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers: A Systematic Review
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Sattar, A. McConnachie, D. O'Reilly, M. N. Upton, I. A. Greer, G. D. Smith, and G. Watt
Inverse Association Between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 583 - 587.
[Abstract] [Full Text]